Sundaram Multi Pap Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Sundaram Multi Pap.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Forestry	38.9%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Sundaram Multi Pap (NSE:SUNDARAM) May Have Issues Allocating Its Capital

Jun 12

Sundaram Multi Pap Limited (NSE:SUNDARAM) Stock Rockets 28% But Many Are Still Ignoring The Company

Feb 24

Here's Why Sundaram Multi Pap (NSE:SUNDARAM) Can Afford Some Debt

Dec 15

Further Upside For Sundaram Multi Pap Limited (NSE:SUNDARAM) Shares Could Introduce Price Risks After 26% Bounce

Sep 06

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Sundaram Multi Pap no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:SUNDARAM - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2024	1,287	-35	88	108	N/A
6/30/2024	1,272	-40	N/A	N/A	N/A
3/31/2024	1,271	-51	35	54	N/A
12/31/2023	1,275	-64	N/A	N/A	N/A
9/30/2023	1,276	-58	153	160	N/A
6/30/2023	1,307	-15	N/A	N/A	N/A
3/31/2023	1,144	26	108	114	N/A
12/31/2022	984	56	N/A	N/A	N/A
9/30/2022	944	87	-8	-1	N/A
6/30/2022	845	81	N/A	N/A	N/A
3/31/2022	704	39	50	54	N/A
12/31/2021	657	3	N/A	N/A	N/A
9/30/2021	568	-35	80	84	N/A
6/30/2021	496	-79	N/A	N/A	N/A
3/31/2021	506	-88	53	56	N/A
12/31/2020	559	-97	N/A	N/A	N/A
9/30/2020	616	-76	7	12	N/A
6/30/2020	717	-52	N/A	N/A	N/A
3/31/2020	970	-27	24	31	N/A
12/31/2019	1,033	23	N/A	N/A	N/A
9/30/2019	1,028	23	93	102	N/A
6/30/2019	1,026	41	N/A	N/A	N/A
3/31/2019	996	59	17	79	N/A
3/31/2018	1,086	-189	N/A	47	N/A
3/31/2017	992	-62	N/A	20	N/A
3/31/2016	985	-87	N/A	231	N/A
3/31/2015	849	-227	N/A	255	N/A
3/31/2014	1,565	-36	N/A	233	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de SUNDARAM es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de SUNDARAM crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de SUNDARAM crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de SUNDARAM crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de SUNDARAM crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SUNDARAM se prevé que sea elevada dentro de 3 años.

Sundaram Multi Pap Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Second quarter 2025 earnings released: ₹0.039 loss per share (vs ₹0.05 loss in 2Q 2024)

Sundaram Multi Pap Limited to Report Q2, 2025 Results on Nov 14, 2024

Sundaram Multi Pap Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 1Q 2024)

Sundaram Multi Pap Limited to Report Q1, 2025 Results on Aug 12, 2024

Sundaram Multi Pap (NSE:SUNDARAM) May Have Issues Allocating Its Capital

Full year 2024 earnings released: ₹0.11 loss per share (vs ₹0.055 profit in FY 2023)

Sundaram Multi Pap Limited (NSE:SUNDARAM) Stock Rockets 28% But Many Are Still Ignoring The Company

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.03 loss in 3Q 2023)

Here's Why Sundaram Multi Pap (NSE:SUNDARAM) Can Afford Some Debt

Second quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.04 profit in 2Q 2023)

Further Upside For Sundaram Multi Pap Limited (NSE:SUNDARAM) Shares Could Introduce Price Risks After 26% Bounce

Sundaram Multi Pap Limited to Report Q4, 2024 Results on May 30, 2024

Sundaram Multi Pap (NSE:SUNDARAM) Takes On Some Risk With Its Use Of Debt

First quarter 2024 earnings released: ₹0.02 loss per share (vs ₹0.07 profit in 1Q 2023)

Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2023

Sundaram Multi Pap Limited to Report Q1, 2024 Results on Aug 11, 2023

Full year 2023 earnings released: EPS: ₹0.05 (vs ₹0.083 in FY 2022)

Sundaram Multi Pap Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 28%

Third quarter 2023 earnings released: ₹0.03 loss per share (vs ₹0.03 profit in 3Q 2022)

Sundaram Multi Pap Limited Appoints DK Mishra as Company Secretary

Is Sundaram Multi Pap (NSE:SUNDARAM) Using Too Much Debt?

Sundaram Multi Pap Limited Appoints DK Mishra as Compliance Officer

Sundaram Multi Pap Limited Announces Resignation of Khushboo Doshi as Company Secretary

Second quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.03 in 2Q 2022)

Sundaram Multi Pap Limited Announced Directorate Appointments

Sundaram Multi Pap Limited to Report Q3, 2023 Results on Feb 14, 2023

First quarter 2023 earnings released: EPS: ₹0.07 (vs ₹0.02 loss in 1Q 2022)

A Look At The Intrinsic Value Of Sundaram Multi Pap Limited (NSE:SUNDARAM)

Investor sentiment improved over the past week

Sundaram Multi Pap Limited to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: ₹0.09 (vs ₹0.19 loss in FY 2021)

Sundaram Multi Pap Limited Announces Resignation of Paresh Jain as Independent Director

Sundaram Multi Pap Limited to Report Q4, 2022 Results on May 30, 2022

Less than half of directors are independent

Less than half of directors are independent

Sundaram Multi Pap Limited Announces Resignation of Minjal Kadakia as Independent Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Is Sundaram Multi Pap (NSE:SUNDARAM) Using Too Much Debt?

Second quarter 2022 earnings released: EPS ₹0.03 (vs ₹0.06 loss in 2Q 2021)

Full year 2021 earnings released: ₹0.19 loss per share (vs ₹0.057 loss in FY 2020)

New 90-day low: ₹1.25

Third quarter 2021 earnings released: ₹0.05 loss per share

Sundaram Multi Pap Limited Approves Appointment of Bhavika Dalal as the Company Secretary & Compliance Officer and Key Managerial Personnel

Sundaram Multi Pap Limited to Report Q3, 2021 Results on Feb 12, 2021

Sundaram Multi Pap Limited Announces the Resignation of Bhavesh Chheda from the Post of Company Secretary & Key Managerial Personnel of the Company

New 90-day high: ₹1.65

Sundaram Multi Pap (NSE:SUNDARAM) Is Carrying A Fair Bit Of Debt

New 90-day high: ₹1.45

New 90-day low: ₹1.10

Would Sundaram Multi Pap (NSE:SUNDARAM) Be Better Off With Less Debt?

New 90-day low - ₹1.25

First quarter earnings released

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento